These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9881826)
21. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417 [TBL] [Abstract][Full Text] [Related]
22. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice. Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021 [TBL] [Abstract][Full Text] [Related]
23. What causes the immune system collapse seen in AIDS? Cohen J Science; 1993 May; 260(5112):1256. PubMed ID: 8098551 [No Abstract] [Full Text] [Related]
24. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia. MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205 [TBL] [Abstract][Full Text] [Related]
25. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. Heeney J; Jonker R; Koornstra W; Dubbes R; Niphuis H; Di Rienzo AM; Gougeon ML; Montagnier L J Med Primatol; 1993; 22(2-3):194-200. PubMed ID: 8105093 [TBL] [Abstract][Full Text] [Related]
26. [Mechanisms of lymphopenia in HIV infection]. Roger PM; Pradier C; Dellamonica P Presse Med; 1994 Jan; 23(2):89-94. PubMed ID: 7908132 [TBL] [Abstract][Full Text] [Related]
28. The drug monosodium luminol (GVT) preserves crypt-villus epithelial organization and allows survival of intestinal T cells in mice infected with the ts1 retrovirus. Scofield VL; Yan M; Kuang X; Kim SJ; Wong PK Immunol Lett; 2009 Feb; 122(2):150-8. PubMed ID: 19186189 [TBL] [Abstract][Full Text] [Related]
29. The role of oxidative imbalance in progression to AIDS: effect of the thiol supplier N-acetylcysteine. Malorni W; Rivabene R; Lucia BM; Ferrara R; Mazzone AM; Cauda R; Paganelli R AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1589-96. PubMed ID: 9840292 [TBL] [Abstract][Full Text] [Related]
30. Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons. Geertsma MF; van Wengen-Stevenhagen A; van Dam EM; Risberg K; Kroon FP; Groeneveld PH; Nibbering PH J Infect Dis; 1999 Sep; 180(3):649-58. PubMed ID: 10438351 [TBL] [Abstract][Full Text] [Related]
31. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion. de Wolf F; Spijkerman I; Schellekens PT; Langendam M; Kuiken C; Bakker M; Roos M; Coutinho R; Miedema F; Goudsmit J AIDS; 1997 Dec; 11(15):1799-806. PubMed ID: 9412697 [TBL] [Abstract][Full Text] [Related]
32. Apoptosis of CD4+ and CD8+ T cells isolated immediately ex vivo correlates with disease severity in human immunodeficiency virus type 1 infection. Cotton MF; Ikle DN; Rapaport EL; Marschner S; Tseng PO; Kurrle R; Finkel TH Pediatr Res; 1997 Nov; 42(5):656-64. PubMed ID: 9357940 [TBL] [Abstract][Full Text] [Related]
33. [Oxidation mechanisms and anti-oxidation in HIV infected patients--effect on disease progression]. Jaruga P Postepy Hig Med Dosw; 1999; 53(1):43-54. PubMed ID: 10352546 [TBL] [Abstract][Full Text] [Related]
34. Impaired immunity in AIDS. The mechanisms responsible and their potential reversal by antiviral therapy. Ruegg CL; Engleman EG Ann N Y Acad Sci; 1990; 616():307-17. PubMed ID: 1981824 [TBL] [Abstract][Full Text] [Related]
35. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection. Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289 [TBL] [Abstract][Full Text] [Related]
36. Oxidative stress and antioxidant capacity in smoking and nonsmoking men with HIV/acquired immunodeficiency syndrome. Cole SB; Langkamp-Henken B; Bender BS; Findley K; Herrlinger-Garcia KA; Uphold CR Nutr Clin Pract; 2005 Dec; 20(6):662-7. PubMed ID: 16306304 [TBL] [Abstract][Full Text] [Related]
37. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Ameisen JC; Capron A Immunol Today; 1991 Apr; 12(4):102-5. PubMed ID: 1676268 [TBL] [Abstract][Full Text] [Related]
38. Cell-cycle dysregulation in the immunopathogenesis of AIDS. Paiardini M; Cervasi B; Dunham R; Sumpter B; Radziewicz H; Silvestri G Immunol Res; 2004; 29(1-3):253-68. PubMed ID: 15181287 [TBL] [Abstract][Full Text] [Related]
39. Effect of L-carnitine treatment in vivo on apoptosis and ceramide generation in peripheral blood lymphocytes from AIDS patients. Cifone MG; Alesse E; Di Marzio L; Ruggeri B; Zazzeroni F; Moretti S; Famularo G; Steinberg SM; Vullo E; De Simone C Proc Assoc Am Physicians; 1997 Mar; 109(2):146-53. PubMed ID: 9069583 [TBL] [Abstract][Full Text] [Related]